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REVIEW ARTICLE
Use of dark chocolate for diabetic patients: a review of the literature and
current evidence
Syed Raza Shaha, Richard Alweisb, Najla Issa Najimc, Amin Muhammad Dharanid,
Muhammad Ahmed Jangdad, Maira Shahidd, Ahmed Nabeel Kazie and Syed Arbab Shahf
aNorth Florida Regional Medical Center, University of Central Florida, Gainesville, FL, USA; bDepartment of Medicine, Rochester Regional
Health System, Rochester, NY, USA; cDepartment of Medicine, University of Kentucky, KY, USA; dDepartment of Internal Medicine, Dow
University of Health Sciences (DUHS), Karachi, Pakistan; eDepartment of Internal Medicine, Chandka Medical College, Larkana, Pakistan;
fDepartment of Internal Medicine, Ziauddin Medical University Hospital, Karachi, Pakistan
ABSTRACT
Dietary changes are a major lifestyle factor that can influence the progression of chronic
diseases such as diabetes. Recently, flavanols, a subgroup of plant-derived phytochemicals
called flavonoids, have gained increasing attention, due to studies showing an inverse
correlation between dietary intake of flavanols and incidence of diabetes. Flavanoids in the
cocoa plant may ameliorate insulin resistance by improving endothelial function, altering
glucose metabolism, and reducing oxidative stress. Oxidative stress has been proposed as the
main culprit for insulin resistance. The well-established effects of cocoa on endothelial
function also points to a possible effect on insulin sensitivity. The relationship between
insulin resistance and endothelial function is a reciprocal one. Overall, the evidence from
these studies suggests that cocoa may be useful in slowing the progression to type 2
diabetes and ameliorating insulin resistance in metabolic syndrome. Additionally, results
from several small studies indicate that cocoa may also have therapeutic potential in
preventing cardiovascular complications in diabetic patients. Studies highlighting the poten-
tial of cocoa-containing diets, in large-randomized controlled trials should be performed
which might give us a better opportunity to analyze the potential health-care benefit for
reducing the risk of complications in diabetic patients at molecular level.
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Dietary changes are a major lifestyle factor that can
influence the progression of chronic diseases such as
diabetes [1]. Recently, flavanols, a subgroup of plant-
derived phytochemicals called flavonoids, have gained
increasing attention, due to studies showing an inverse
correlation between dietary intake of flavanols and inci-
dence of diabetes [2–4]. Foods rich in dietary flavonoids
have therefore been targeted as potential dietary
adjuncts in the management of diabetes [5].
Dark chocolate is one such food and, historically,
chocolate was used for healing purposes [6]. Foods
and beverages made from beans from the Theobroma
cacao tree have been consumed by humans since at
least around 500 AD [7]. However, chocolate con-
sumption has been on the rise in recent years with
wider availability of commercially-produced pro-
ducts. Worldwide, chocolate consumption ranges
from 120 g per person per year in China to around
12 000 g per person per year in Ireland. The USA is
in the middle of this range, with consumption of
approximately 500 g per person per year [8]. The
focus of research on dark chocolate to date has been
primarily on its effect on cardiovascular risk, though
there are studies indicating the potential benefit of
dark chocolate consumption on other organ systems
and conditions [9]. This article reviews the effects of
dark chocolate consumption on glucose metabolism
with suggestions for future research.
2. Positive effects
2.1. Dark chocolate and pre-clinical studies
Flavanoids in the cocoa plant may ameliorate insulin
resistance by improving endothelial function, altering
glucose metabolism, and reducing oxidative stress [2–
5]. Oxidative stress has been proposed as the main
culprit for insulin resistance [10]. This hypothesis is
supported by the observation that many anti-diabetic
drugs demonstrate antioxidant effects. This effect
may be direct – as in the case of calcium channel
blockers (CCBs), angiotensin-converting enzyme
(ACE) inhibitors, and statins – or indirect – as in
glinides and acarbose, which prevent oxidative stress
caused by postprandial hyperglycemia [10]. If this
hypothesis is proved correct, the demonstrated anti-
oxidant activity of dark chocolate could theoretically
also protect against insulin resistance [11]. However,
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there is presently stronger evidence for an insulin-
sensitizing effect mediated by altered glucose meta-
bolism and changes in endothelial function [11].
Many polyphenols, including epicatechin and cate-
chin, have been found to alter glucose metabolism in
in vitro laboratory studies [12]. Similarly to acarbose,
the epicatechin and catechin in dark chocolate inhibit
alpha-glucosidase activity [13]. These compounds
have also been shown to inhibit absorption of glucose
from the intestine [13]. In in vivo studies, diabetic rat
models confirmed the insulin-sensitizing effect of
dark chocolate. In two such studies, epicatechin
increased insulin secretion and regenerated pancrea-
tic β-cells [13–15]. Similarly, supplementation of dia-
betic rats with cocoa extract for four weeks was dose-
dependently associated with reduced serum glucose,
post-prandial hyperglycemia, atherogenic lipid levels,
insulin resistance, and 8-isoprostane, a biomarker of
oxidative stress [14–17]. These studies established the
efficacy of cocoa extract/dark chocolate in reducing
insulin resistance in animals.
2.2. Dark chocolate and human studies
Similarly, positive effects of cocoa have also been found
in human studies. The well-established effects of cocoa
on endothelial function also points to a possible effect
on insulin sensitivity in human studies. The relation-
ship between insulin resistance and endothelial func-
tion is a reciprocal one. Decreased insulin sensitivity
worsens endothelial function; conversely, a decline in
endothelial function can decrease insulin sensitivity
[18]. In healthy individuals, insulin increases blood
flow to skeletal muscles and glucose uptake by muscle
cells through vasodilation. In contrast, in insulin-
resistant individuals, insulin-mediated vasodilation is
impaired leading to impaired glucose disposal. Insulin
resistance has been associated with reduced activity of
endothelium-derived nitric oxide synthase (NOS) with
subsequent increased plasma levels of asymmetric
dimethylarginine (ADMA), which is an endogenous
NOS inhibitor [19]. Elevated ADMA levels therefore
lead to impaired endothelial function and promotion
of atherosclerosis [19,20]. Thus, the availability of nitric
oxide (NO) likely plays a role in initiating cellular
response to insulin. The ability of cocoa extract to
increase bioavailability of NO and the possible relation-
ship between dark chocolate consumption and insulin
resistance led to several investigations in human special
populations, particularly the hunter-gatherer Kuna in
Panama, whom have significantly lower cardiovascular
disease and cancer death rates than the USA population
and a higher consumption of cocoa-containing bev-
erages when living on the Ailigandi Islands, but have
increasingly migrated to urban areas and adopted a
more Western diet with subsequent increases in cardi-
ovascular disease, diabetes, and cancer [21].
In this population, ingestion of a more traditional
amount of flavonoid-rich dark chocolate for 15 days
was associated with improved endothelial function
and improved insulin sensitivity in hypertensive,
urbanized Kuna [22,23]. These results were replicated
in healthy individuals as well as in hypertensive
patients with impaired glucose tolerance [23]. In the
former study, subjects received oral glucose tolerance
tests (OGTT) after consuming either dark chocolate
or white chocolate for 15 days. Compared with white
chocolate, ingestion of dark chocolate was associated
with lower quantitative insulin-sensitivity check
index values and higher homeostasis model insulin
resistance (HOMA-IR) values [22]. In the latter
study, hypertensive, glucose-intolerant subjects also
received OGTT after 15 days of daily consumption
of either flavanol-rich dark chocolate or white cho-
colate [23]. Therefore, dark chocolate increased β-cell
function, increased insulin sensitivity, and decreased
HOMA-IR, compared to white chocolate.
Similarly, cocoa-rich foods showed significant effect
insulin sensitivity in those patients with insulin resistance
on the basis of weight indices. Insulin sensitivity
improved significantly in non-diabetic overweight adults
consuming high-flavanol cocoa (900 g flavanols) for
12 weeks compared to low-flavanol cocoa [24]. Cocoa’s
effects on insulin resistance may be dependent on its
continual consumption over a longer period of time.
Two studies have indicated improvements within two
weeks of insulin-mediated vasodilation (through
increased NOS levels) and fasting capillary whole blood
glucose, but the two week trial period did not demon-
strate improved measures of insulin resistance [20,25].
2.3. Dark chocolate and effect on gut microbe
Another important discussion is the effect of dark cho-
colate and flavanols on gut microbe. Most of the effects
are individualized to the type of microorganisms. The
bioavailability and effects of polyphenols greatly depend
on their transformation by components of the gut
microbiota. For example, gram-negative bacteria are
more resistant to flavanols owing to their different
wall composition, as compared to gram-positive bac-
teria [26]. Effects can also be modified by bacterial
growth andmetabolism of flavanols and dark chocolate.
Studies suggest a dose-dependent activity of flavanols
on bacteria, inhibiting their growth [27–29]. Some stu-
dies suggest that bacteria in the gut may also be affected
by the production of hydrogen peroxide produced by
substances in flavanols [29].
On the other hand, flavanols in dark chocolate inhibit
toxins in bacteria like H.Pylori, including suppression of
urease, hence, damaging bacterial membranes [30]. Few
studies have also linked affects of flavanols on gut
microbe as protective against various cancers. However,
the exact mechanism of action are unknown [31].
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It is clear that dietary polyphenols and their meta-
bolites contribute to the maintenance of gut health by
the modulation of the gut microbial balance through
the stimulation of the growth of beneficial bacteria
and the inhibition of pathogen bacteria, exerting pre-
biotic-like effects. However, data on the impact of
polyphenols on the gut microbiota and their mechan-
isms of action in humans are scarce. In addition, a
better understanding of the dietary phenolic and gut
microbiota relationship by the combination of meta-
genomic and metabolomic studies provides more
insight into the health effects of polyphenols.
2.4. Dark chocolate and arterial stiffness
In a one-year intervention study of postmenopausal
Type 2 diabetes patients, daily dark chocolate consump-
tion had a positive effect on arterial stiffness in a sub-
group analysis of 35 participants [32]. In a cross-over
study where healthy participants were assigned to
receive five treatments of daily intake of cocoa power
with different doses of flavanols for one week each,
cocoa consumption improved arterial stiffness [32,33].
Overall, the evidence from these studies suggests
that cocoa may be useful in slowing the progression
to type 2 diabetes and ameliorating insulin resistance
in metabolic syndrome. Additionally, results from
several small studies indicate that cocoa may also
have therapeutic potential in preventing cardiovascu-
lar complications in diabetic patients. In one such
study, flavanol-rich cocoa consumption three times
daily for 30 days increased flow-mediated dilatation
by 30% in medicated diabetics [23].
Although large-scale studies in humans with dia-
betes are lacking, animal studies, small-scale human
studies, and biological plausibility support potential
beneficial effects of cocoa on glucose control, with
possible reductions in cardiovascular risk in diabetics.
Additional larger scale studies to confirm these effects
in humans are therefore needed.
3. Negative effects
Dark chocolate is commonly regarded as an energy-
dense food and excess consumption of any energy-
dense food may have adverse metabolic effects,
including weight gain [32]. While several short-
term (i.e., 2–8 weeks) studies have examined
changes in body weight following consumption of
chocolate, only one study, performed in overweight
and obese women, has compared the effects of
chocolate against non-chocolate intake specifically
on changes in body weight and composition during
energy restriction [34,35]. In this feasibility study,
inclusion of a dark chocolate or non-chocolate
sweet snack as part of the diet resulted in losses
in fat mass, body weight and body fat percentage,
with no significant differences between the two
snack groups. However, the sample size of this
pilot study was small, and outcomes were limited
to body composition and without further explora-
tion of biomarkers of metabolic health [34].
The majority of these studies lacked a true control
arm and few studies on the effects of consumption on
weight used dark chocolate. All of the studies either
used white chocolate, cocoa butter, or chocolate bars
without flavanols as a control, in order to create
conditions with equal energy intake. For ethical rea-
sons, deliberate attempts were made to avoid positive
energy balance in participants with an increased risk
for chronic diseases. Therefore, during both the inter-
vention (chocolate) and control (no chocolate/pla-
cebo) periods, the energy intake in the habitual diet
was reduced by ways of reducing the participant’s
daily snack consumption. However, it is not clear
whether these control ‘placebos’ are neutral, since it
cannot be excluded that the placebo itself might have
included something which led to physiologic effects
and detected changes. Therefore, while it is possible
that there are deleterious effects of dark chocolate
consumption on diabetics, appropriate studies to
assess this have not yet been performed.
4. Summary
In summary, there are plausible mechanisms for the
antioxidant effects of cocoa polyphenols to directly
influence insulin resistance and, in turn, reduce risk
for diabetes. Cocoa may induce pancreatic β-cell
regeneration and stimulate insulin secretion, have a
hypoglycemic effect, and improve glucose tolerance.
The vasodilatory effects of cocoa can also improve
insulin sensitivity mediated by endothelial function.
Sustained consumption of cocoa over long periods
may affect insulin resistance to a greater degree than
single doses of cocoa products. Studies highlighting the
potential of cocoa-containing diets, in large-
randomized controlled trials should be performed
which might give us a better opportunity to analyze
the potential health care benefit for reducing the risk
of complications in diabetic patients at molecular level.
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